Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Emerald Health Therapeutics Inc (EMH.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX-V]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX-V]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 446,965
  • Shares Outstanding, K 93,118
  • Annual Sales, $ N/A
  • Annual Income, $ N/A
  • 36-Month Beta 3.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.86
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.02 on 09/30/17
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.100 +134.29%
on 11/16/17
5.480 -10.22%
on 12/13/17
+2.470 (+100.82%)
since 11/15/17
3-Month
1.200 +310.00%
on 09/18/17
5.480 -10.22%
on 12/13/17
+3.730 (+313.45%)
since 09/15/17
52-Week
1.030 +377.67%
on 03/22/17
5.480 -10.22%
on 12/13/17
+3.540 (+256.52%)
since 12/15/16

Most Recent Stories

More News
Emerald Health Announces No Material Change

Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (the "Company") is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment...

EMHTF : 3.7984 (-2.17%)
EMH.VN : 4.920 (-0.40%)
Research Reports on OrganiGram Holdings, IntelGenx Technologies, Antibe Therapeutics, and Emerald Health Therapeutics

LONDON, UK / ACCESSWIRE / December 07, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: OrganiGram Holdings, IntelGenx...

EMHTF : 3.7984 (-2.17%)
IGXT : 0.6964 (+7.14%)
OGRMF : 2.9300 (-4.56%)
EMH.VN : 4.920 (-0.40%)
OGI.VN : 3.750 (-4.58%)
ATBPF : 0.1054 (-4.18%)
ATE.VN : 0.140 (+3.70%)
IGX.VN : 0.890 (+3.49%)
Emerald Health Plans for 1,000,000 Square Feet of Cultivation Space by End of 2018 -- CFN Media

CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Emerald Health Therapeutics Inc.'s (TSX-V: EMH) (OTCQX:...

EMHTF : 3.7984 (-2.17%)
EMH.VN : 4.920 (-0.40%)
North American Cannabis Operations Expanding at a Swift Pace to Meet Rising Consumer Demand

As the cannabis, legal marijuana and hemp industry continues to mature and consumer demand in turn rapidly rises, leaders are staying ahead of the curve through the expansion of grow operations in order...

EMHTF : 3.7984 (-2.17%)
NXTTF : 0.9828 (+1.56%)
GLH.CN : 0.305 (unch)
N.CN : 1.230 (+1.65%)
FFRMF : 0.4477 (-2.67%)
FFT.CN : 0.610 (-3.17%)
GLDFF : 0.2263 (-6.87%)
MYM.CN : 3.150 (+11.70%)
EMH.VN : 4.920 (-0.40%)
MYMMF : 2.5800 (+5.31%)
Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) ("Emerald" or the "Company") announces that it acquired today 1,666,6667 units (the "Units") of Vanc Pharmaceuticals Inc. ("Vanc") of Suite 810...

NUVPD : 0.1543 (-9.24%)
EMHTF : 3.7984 (-2.17%)
EMH.VN : 4.920 (-0.40%)
Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fourth Facility

Construction of first 75,000 square feet of new greenhouse targeted for completion in March 2018; next expansion phase to over 500,000 square feet to be completed by end 2018

EMHTF : 3.7984 (-2.17%)
EMH.VN : 4.920 (-0.40%)
Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

SEATTLE, WA--(Marketwired - Nov 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the...

EMHTF : 3.7984 (-2.17%)
ATT.CN : 0.500 (-16.67%)
EMH.VN : 4.920 (-0.40%)
ATTBF : 0.4390 (+11.22%)
Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp....

EMHTF : 3.7984 (-2.17%)
ATT.CN : 0.500 (-16.67%)
EMH.VN : 4.920 (-0.40%)
ATTBF : 0.4390 (+11.22%)
Abattis Announces Completion of Investment by Emerald Health Therapeutics in Northern Vine

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce the closing of its previously announced agreement with Emerald Health Therapeutics Inc. ("Emerald")...

EMHTF : 3.7984 (-2.17%)
ATT.CN : 0.500 (-16.67%)
EMH.VN : 4.920 (-0.40%)
ATTBF : 0.4390 (+11.22%)
Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

Emerald Health Therapeutics Inc. ("Emerald") (TSX-V:EMH) (OTCQX:EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. ("Northern...

EMHTF : 3.7984 (-2.17%)
ATT.CN : 0.500 (-16.67%)
EMH.VN : 4.920 (-0.40%)
ATTBF : 0.4390 (+11.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Key Turning Points

2nd Resistance Point 5.233
1st Resistance Point 5.077
Last Price 4.920
1st Support Level 4.807
2nd Support Level 4.693

See More

52-Week High 5.480
Last Price 4.920
Fibonacci 61.8% 3.780
Fibonacci 50% 3.255
Fibonacci 38.2% 2.730
52-Week Low 1.030

See More

Business Summary

Emerald Health Therapeutics Inc through its wholly-owned subsidiary is engaged in cultivation and selling of medical cannabis out of its facility located in Victoria, British Columbia.

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.